AAV9-mediated erythropoietin gene transfer to the rat brain in a rat model of Parkinson's disease

被引：0
|
作者：
Xue, Y. -Q. [1 ]
Tatom, J. B. [2 ]
Jiang, L. -X. [3 ]
Zhao, L. -R. [4 ,5 ]
Klein, R. L. [2 ,5 ]
Duan, W. -M. [1 ,5 ]
机构：
[1] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA
[3] Vector Gene Technol Co, Beijing, Peoples R China
[4] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71105 USA
[5] Louisiana State Univ, Hlth Sci Ctr, Gene Therapy Program, Shreveport, LA 71105 USA
来源：
CELL TRANSPLANTATION | 2008年 / 17卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
引用
收藏
页码：486 / 486
页数：1
相关论文
共 50 条
  • [41] Behavioral effects and gene delivery in a rat model of parkinson's disease
    Science, 5225 (856):
  • [42] Parkin gene therapy for α-synucleinopathy:: A rat model of Parkinson's disease
    Mochizuki, Hideki
    Yamada, Masanori
    Mizuno, Yoshikuni
    PARKINSONISM & RELATED DISORDERS, 2006, 12 : S107 - S109
  • [43] Correction of visual and auditory function by AAV9-mediated gene therapy in a mouse model of mucopolysaccharidosis type IIIB
    Ribera, A.
    Motas, S.
    Ramirez, L.
    Marco, S.
    Sanchez, V.
    Sanchez, X.
    Bertolin, J.
    Perez, J. A.
    Leon, X.
    Varela-Nieto, I.
    de la Villa, P.
    Haurigot, V.
    Bosch, F.
    HUMAN GENE THERAPY, 2017, 28 (12) : A67 - A67
  • [44] Correction of Visual and Auditory Function by AAV9-Mediated Gene Therapy in a Mouse Model of Mucopolysaccharidosis Type IIIB
    Ribera, Albert
    Motas, Sandra
    Ramirez, Laura
    Marco, Sara
    Sanchez, Victor
    Sanchez, Xavier
    Bertolin, Joan
    Perez, Jennifer A.
    Leon, Xavier
    Varela-Nieto, Isablel
    de la Villa, Pedro
    Haurigot, Virginia
    Bosch, Fatima
    MOLECULAR THERAPY, 2018, 26 (05) : 114 - 114
  • [45] Electrophysiological Consequences of AAV9 mediated SERCA2a Gene Transfer to Normal Rat Myocardium
    Xie Chaoqin
    Jeong, Dongtak
    Kohlbrenner, Erik
    Hajjar, Roger J.
    Akar, Fadi G.
    CIRCULATION RESEARCH, 2014, 115
  • [46] AAV9-mediated VEGF-B Gene Transfer Improves Systolic Function in Progressive Left Ventricular Hypertrophy
    Huusko, Jenni
    Lottonen, Line
    Merentie, Mari
    Gurzeler, Erika
    Anisimov, Andrey
    Miyanohara, Atsushi
    Alitalo, Kari
    Tavi, Pasi
    Yla-Herttuala, Seppo
    MOLECULAR THERAPY, 2012, 20 (12) : 2212 - 2221
  • [47] AAV1/2-mediated BDNF gene therapy in a transgenic rat model of Huntington's disease
    Connor, B.
    Sun, Y.
    von Hieber, D.
    Tang, S. K.
    Jones, K. S.
    Maucksch, C.
    GENE THERAPY, 2016, 23 (03) : 283 - 295
  • [48] AAV1/2-mediated BDNF gene therapy in a transgenic rat model of Huntington’s disease
    B Connor
    Y Sun
    D von Hieber
    S K Tang
    K S Jones
    C Maucksch
    Gene Therapy, 2016, 23 : 283 - 295
  • [49] AAV-mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa
    Smith, AJ
    Schlichtenbrede, FC
    Tschernutter, M
    Bainbridge, JW
    Thrasher, AJ
    Ali, RR
    MOLECULAR THERAPY, 2003, 8 (02) : 188 - 195
  • [50] Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Aβ levels
    Patricia A Lawlor
    Ross J Bland
    Pritam Das
    Robert W Price
    Vallie Holloway
    Lisa Smithson
    Bridget L Dicker
    Matthew J During
    Deborah Young
    Todd E Golde
    Molecular Neurodegeneration, 2
12345